ArticleFrontiers in cellular and infection microbiology2025
Auxin-mediated biosynthesis of silver nanoparticles: comprehensive characterisation and antibacterial activity analysis.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Nitric oxide-releasing responsive biomaterials for antimicrobial skin therapy.Redox biology · 2026Review
- Facile synthesis of Sarcochlamys pulcherrima mediated silver nanoparticles for antibacterial, antibiofilm, and network pharmacology evaluation.Scientific reports · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Silver nanoparticles (AgNPs) are well-known for their potent antibacterial properties. However, the rise of antibiotic-resistant bacteria highlights the need for alternative antimicrobial strategies. Green synthesis using biological molecules offers an eco-friendly route to nanoparticle production. Objective: This study aims to synthesise AgNPs using plant growth hormones (Auxins), specifically indole-3-acetic acid (IAA) and indole-3-butyric acid (IBA), and to evaluate their antibacterial activity against pathogenic bacteria. Methods: AgNPs were synthesised using IAA and IBA as reducing and stabilising agents. The synthesised nanoparticles were characterised by UV-Visible spectroscopy, Fourier Transform Infrared Spectroscopy (FTIR), Particle Size Analysis, Dynamic Light Scattering (DLS) for hydrodynamic diameter, Zeta potential for surface charge, and Field Emission Scanning Electron Microscopy (FE-SEM) for morphological analysis. Antibacterial assays were performed against Results: The IAA and IBA-mediated AgNPs showed controlled size distribution, stability, and uniform morphology. Enhanced antibacterial activity was observed, particularly against Conclusion: IAA and IBA-mediated synthesis provide a green, sustainable method for producing AgNPs with significant antibacterial potential. These Auxin-based AgNPs represent promising candidates for combating antibiotic-resistant bacterial strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.